BioLineRx Ltd (BLRX) — Working Capital to Net Assets Ratio
BioLineRx Ltd (BLRX) has a Working Capital to Net Assets ratio of 16.1% as of June 2026. Working capital of $2.67 Million (current assets of $16.35 Million minus current liabilities of $13.68 Million) is measured against net assets of $16.62 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See BioLineRx Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
BioLineRx Ltd Working Capital to Net Assets (2008–2025)
This chart shows how BioLineRx Ltd's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at 16.1%, reflecting working capital of $2.67 Million against net assets of $16.62 Million USD. For the complete balance sheet picture, see total assets of BioLineRx Ltd.
Annual Working Capital to Net Assets for BioLineRx Ltd (2008–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for BioLineRx Ltd from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check BLRX asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 49.5% | $11.56 Million | $23.34 Million | $23.68 Million | $12.12 Million | ▼ -37.4 pp |
| 2024 | 86.9% | $11.70 Million | $13.46 Million | $27.10 Million | $15.41 Million | ▲ +53.6 pp |
| 2023 | 33.3% | $4.40 Million | $13.22 Million | $47.18 Million | $42.78 Million | ▼ -48.0 pp |
| 2022 | 81.3% | $41.32 Million | $50.84 Million | $52.00 Million | $10.68 Million | ▲ +11.2 pp |
| 2021 | 70.0% | $47.69 Million | $68.09 Million | $57.40 Million | $9.72 Million | ▲ +14.5 pp |
| 2020 | 55.6% | $12.24 Million | $22.03 Million | $22.88 Million | $10.64 Million | ▲ +6.9 pp |
| 2019 | 48.7% | $16.24 Million | $33.38 Million | $28.21 Million | $11.97 Million | ▼ -12.4 pp |
| 2018 | 61.1% | $25.23 Million | $41.32 Million | $31.98 Million | $6.75 Million | ▼ -21.5 pp |
| 2017 | 82.6% | $43.65 Million | $52.88 Million | $50.38 Million | $6.72 Million | ▼ -10.1 pp |
| 2016 | 92.6% | $32.44 Million | $35.03 Million | $36.10 Million | $3.66 Million | ▼ -2.0 pp |
| 2015 | 94.6% | $45.04 Million | $47.61 Million | $48.18 Million | $3.14 Million | ▼ -6.8 pp |
| 2014 | 101.4% | $32.21 Million | $31.77 Million | $35.11 Million | $2.90 Million | ▼ -33.2 pp |
| 2013 | 134.6% | $15.72 Million | $11.68 Million | $18.77 Million | $3.05 Million | ▲ +29.3 pp |
| 2012 | 105.2% | $15.75 Million | $14.97 Million | $22.18 Million | $6.43 Million | ▲ +14.7 pp |
| 2011 | 90.5% | $20.40 Million | $22.53 Million | $27.16 Million | $6.75 Million | ▼ -3.4 pp |
| 2010 | 93.9% | $35.00 Million | $37.26 Million | $41.27 Million | $6.27 Million | ▲ +4.2 pp |
| 2009 | 89.7% | $27.93 Million | $31.13 Million | $38.82 Million | $10.88 Million | ▲ +6.5 pp |
| 2008 | 83.2% | $17.27 Million | $20.75 Million | $27.15 Million | $9.88 Million | — |